Google's AI co-scientist independently reproduces an unpublished superbug discovery in 48 hours
Google's Gemini 2.0–based multi-agent 'AI co-scientist' (announced 19 Feb 2025) generated hypotheses that were validated in the lab. It proposed AML drug-repurposing candidates, and liver-fibrosis drugs active in human organoids. Its top-ranked hypothesis for how cf-PICI genetic elements spread between bacteria matched Imperial College's unpublished, experimentally confirmed finding. The system was published in Nature on 19 May 2026.
Key facts
- Agents for generation, reflection, ranking (tournament), evolution and meta-review on Gemini 2.0
- cf-PICI: 5 ranked hypotheses in 48 hours; the top one (hijacking tails from diverse phages) matched José Penadés's unpublished result; both papers later in Cell (Sep 2025)
- Liver fibrosis: 2 of the co-scientist's recommended epigenetic drugs were anti-fibrotic in human hepatic organoids (vorinostat reduced TGFβ-induced chromatin changes by 91%)
- AML: repurposing candidates inhibited tumour viability in cell lines
- Caveats: evaluation not blind or pre-registered; Google staff co-authors; 'decade-long mystery solved in 2 days' is press framing
Science result
- Field
- biology / microbiology / drug repurposing
- Problem
- Mechanism of cf-PICI host-range expansion; drug repurposing for AML and liver fibrosis
- Result
- AI-generated hypotheses matching an unpublished discovery and identifying lab-validated drug candidates.
- AI system
- AI co-scientist (Gemini 2.0)
- Human role
- AI-assisted: scientists pose goals; lab validation by humans
- Verification
- Peer-reviewed in Cell (cf-PICI), Advanced Science (fibrosis) and Nature (system, 2026); lab-validated
- Status
- confirmed
- Why surprising
- Penadés said he initially thought Google had accessed his unpublished data, because the AI's top hypothesis matched his group's years-long result.
What happened
Google built a multi-agent system that debates and ranks research hypotheses. Partner labs tested its suggestions, and one matched an unpublished result the humans had spent years on.
Why it matters
It was the most-cited early example of an LLM system generating a correct, non-obvious scientific hypothesis. At Google I/O 2026 it became part of the "Gemini for Science" product.
Changelog
- 2026-09-29: created
- 2026-09-29: linked the I/O 2026 'Gemini for Science' product entry (Co-Scientist became a Labs tool and enterprise preview)
Related events
- FutureHouse's Robin multi-agent system proposes ripasudil as a new treatment candidate for dry AMD ★★★
- Edison Scientific's Kosmos AI scientist claims six months of research per run ★★★
- Google launches 'Gemini for Science' at I/O 2026: Co-Scientist, AlphaEvolve and ERA become products ★★★
- Stanford's 'Virtual Lab' of AI agents designs SARS-CoV-2 nanobodies validated in the lab ★★★
- Google's C2S-Scale 27B model generates a new cancer-immunotherapy hypothesis confirmed in living cells ★★★
Sources (5)
- paperCo-Scientist paper (Nature, 2026)
- paperCell: AI co-scientist and the cf-PICI mechanism
- paperbioRxiv: cf-PICI hypothesis generated by AI co-scientist
- paperAdvanced Science: AI-assisted liver fibrosis drug repurposing
- pressHPCwire: Google unveils AI scientist
id: 2025-02-19-google-ai-co-scientist · updated 2026-09-29 · open in the interactive timeline